Table 3 Measurement of the total no. of ulcers, ulcer index, inhibition percentage, mucus and pH

Group 1

Control (FR^a)

2.7 ± 0.65^*

0.85 ± 0.52^*

14 ± 2.20^*

17 ± 1.80^*

0.00^*

Group 2

control (MR^b)

2.95 ± 0.21^*

0.43 ± 0.14^*

16.5 ± 4.20^*

23.5 ± 7.30^*

0.00^*

Group 3

Omeprazole

4.37 ± 0.32^#

1.2 ± 0.20^#

5 ± 2.10^#

8 ± 6.13^#

65.95^#

Group 4

EOTa (MR)

3.1 ± 0.80^*#

0.42 ± 0.40^*#

13 ± 0.70^*#

14.83 ± 1.70^*#

36.90^*#

Group 5

EOTa (MR)

3.42 ± 0.87^*#

0.8 ± 0.20^*#

10 ± 1.80^*#

11.42 ± 3.80^*#

51.40^*#

Group 6

EOTa (MR)

5.79 ± 0.22^*#

2.2 ± 0.80^*#

1.5 ± 0.32^*#

2.82 ± 2.21^*#

88.00^*#

Group 7

EOTa (FR)

5.13 ± 0.26^*#

2.55 ± 0.32^*#

3.5 ± 2.70^*#

5.3 ± 1.67^*#

77.44^*#

Group 8

EOTa (FR)

5.88 ± 0.20^*#

2.85 ± 0.46^*#

0.84 ± 1.33^*#

0.88 ± 0.22^*#

96.25^*#

Group 9

EOTa (FR)

6.14 ± 0.38^*#

3.18 ± 0.72^*#

0.25 ± 0.05^*#

0.27 ± 0.93^*#

98.85^*#